CTKB
Cytek Biosciences Inc
5.30$
+1.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.5% | 44.3% | 38.1% | 38.4% | 43.3% | 44.6% | 48.2% | |
| 49.5% | 55.7% | 61.9% | 61.6% | 56.7% | 55.4% | 51.8% | |
| 15.4% | 14.7% | 19.1% | 21.3% | 22.9% | 19.7% | 18.1% | |
| 11.6% | 10.1% | 16.3% | 21.1% | 22.8% | 21.5% | 29.2% | |
| 79.3% | 41.0% | 54.7% | 62.7% | 71.1% | 65.7% | 71.9% | |
| -29.8% | 14.7% | 7.2% | -1.1% | -14.4% | -10.2% | -20.0% | |
| 0.0% | 0.4% | 1.4% | 1.6% | 1.1% | 2.6% | 0.2% | |
| -28.1% | 15.5% | 4.6% | 0.8% | -8.1% | -2.8% | -14.8% | |
| 0.9% | -5.4% | 2.3% | -0.7% | -1.8% | 0.2% | 18.2% | |
| -29.1% | 20.9% | 2.3% | 1.6% | -6.3% | -3.0% | -33.0% | |
| -27.6% | 16.6% | 7.0% | 5.8% | -2.3% | 2.4% | -8.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.